98%
921
2 minutes
20
BackgroundCervical cancer is the fourth most common cause of women cancer deaths worldwide. The primary etiology of cervical cancer is the persistent infection of specific high-risk strains of the human papillomavirus. Liquid-based cytology is the established method for early detection of cervical cancer. The evaluation of cellular abnormalities at a microscopic level allows for the identification of malignant or precancerous features in liquid-based cytology pap smears. This technique is characterized by its time-consuming nature and susceptibility to both inter- and intra-observer variability. Hence, the utilization of Artificial Intelligence in computer-assisted diagnosis can reduce the duration needed for diagnosing this ailment, thereby eliminating delayed diagnosis and facilitating the implementation of an efficient treatment.ObjectiveThis research presents a new deep learning-based cervical cancer identification decision support system in liquid-based cytology smear images.MethodsThe proposed diagnosis support system incorporates a novel hybrid feature reduction and optimization module, which integrates a sparse Autoencoder with the Binary Harris Hawk metaheuristic optimization algorithm to select the most informative features from a supplemented feature set of the input images. The supplemented feature set is retrieved by three pretrained Convolutional Neural Networks. The module utilizes an improved feature set to conduct a Bayesian-optimized K Nearest Neighbors machine learning classification of cervical cancer in input Pap smears.ResultsThe introduced approach achieves a classification accuracy of 99.9% and demonstrates an improved ability to detect the stages of cervical cancer, with a sensitivity of 99.8%. In addition, the system has the ability to identify the lack of cervical cancer stages with a specificity rate of 99.9%.ConclusionThe proposed system outpaces recent deep learning-based cervical cancer identification systems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/09287329251330081 | DOI Listing |
Int J Gen Med
September 2025
Suzhou Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.
Purpose: The fourth most common cause of cancer-related deaths in women is cervical cancer. Though treatment of early-stage cervical cancer is often effective, middle and advanced stage cervical cancer is hard to treat and prone to recurrence. We sought to explore the mechanism underlying cervical cancer progression to identify new therapeutic approaches.
View Article and Find Full Text PDFFront Immunol
September 2025
Department of Medicine, Division of Hematology, Bioclinicum and Center for Molecular Medicine, Karolinska Institute and Karolinska University Hospital Solna, Stockholm, Sweden.
Background: Metabolic reprogramming is an important hallmark of cervical cancer (CC), and extensive studies have provided important information for translational and clinical oncology. Here we sought to determine metabolic association with molecular aberrations, telomere maintenance and outcomes in CC.
Methods: RNA sequencing data from TCGA cohort of CC was analyzed for their metabolic gene expression profile and consensus clustering was then performed to classify tumors into different groups/subtypes.
Front Microbiol
August 2025
Department of Immunology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
The genus is a heterogenous group of commensal and pathogenic bacteria. Members of this genus are classified into two major groups, the pyogenic group and the viridans group streptococci (VGS). VGS are frequently found as normal members of the human microbiome and are regarded as commensals.
View Article and Find Full Text PDFBiochem Biophys Rep
June 2025
The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China.
Background: SLC16A3, a highly expressed H + -coupled symporter, facilitates lactate transport via monocarboxylate transporters (MCTs), contributing to acidosis. Although SLC16A3 has been implicated in tumor development, its role in tumor immunity remains unclear.
Methods: A pan-cancer analysis was conducted using datasets from The Cancer Genome Atlas, Cancer Cell Line Encyclopedia, and Genotype-Tissue Expression projects.
Surg Case Rep
September 2025
Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan.
Introduction: There are no reports of patients undergoing McKeown esophagectomy for esophageal cancer after undergoing pancreaticoduodenectomy for pancreatic cancer. We report the case of a patient who underwent subtotal esophagectomy and colon reconstruction after pancreaticoduodenectomy using the mesenteric approach.
Case Presentation: A 71-year-old male was diagnosed with advanced esophageal cancer.